Treatment of Proprietary Information. Except as otherwise provided in this Article 11, during the term of this Agreement and for a period of five (5) years following expiration or termination thereof, a party (the "Receiving Party") will retain in confidence and use only for purposes of this Agreement Proprietary Information supplied by or on behalf of the other party (the "Disclosing Party"). For purposes of this Article 11, all such Proprietary Information which a Receiving Party is obligated to retain in confidence shall be disclosed in written form and marked "Confidential" or with similar designation, or if originally disclosed visually or orally, reduced to such written form within thirty (30) days of such original disclosure.
Appears in 5 contracts
Samples: License Agreement (Keryx Biopharmaceuticals Inc), License Agreement (Keryx Biopharmaceuticals Inc), License Agreement (Keryx Biopharmaceuticals Inc)
Treatment of Proprietary Information. Except as otherwise provided in this Article 1115, during the term of this Agreement and for a period of five (5) years following expiration or termination thereof, a party (the "Receiving Party") will retain in confidence and use only for purposes of this Agreement Proprietary Information supplied by or on behalf of the other party (the "Disclosing Party"). For purposes of this Article 1115, all such Proprietary Information which a Receiving Party is obligated to retain in confidence shall be disclosed in written form and marked "Confidential" or with similar designation, or if originally disclosed visually or orally, reduced to such written form within thirty (30) days of such original disclosure.
Appears in 2 contracts
Samples: Sublicense Agreement (Keryx Biopharmaceuticals Inc), Sublicense Agreement (Keryx Biopharmaceuticals Inc)
Treatment of Proprietary Information. Except as otherwise provided in this Article 1115, during the term of this Agreement and for a period of five (5) years following expiration or termination thereof, a party (the "“Receiving Party"”) will retain in confidence and use only for purposes of this Agreement Proprietary Information supplied by or on behalf of the other party (the "“Disclosing Party"”). For purposes of this Article 1115, all such Proprietary Information which a Receiving Party is obligated to retain in confidence shall be disclosed in written form and marked "“Confidential" ” or with similar designation, or if originally disclosed visually or orally, reduced to such written form within thirty (30) days of such original disclosure.
Appears in 2 contracts
Samples: Sublicense Agreement (Keryx Biopharmaceuticals Inc), Sublicense Agreement (Keryx Biopharmaceuticals Inc)